Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial.
Porter JC, Inshaw J, Solis VJ, Denneny E, Evans R, Temkin MI, De Vasconcelos N, Aramburu IV, Hoving D, Basire D, Crissell T, Guinto J, Webb A, Esmail H, Johnston V, Last A, Rampling T, Lippert L, Helbig ET, Kurth F, Williams B, Flynn A, Lukey PT, Birault V, Papayannopoulos V.
Porter JC, et al. Among authors: guinto j.
Elife. 2024 Jul 16;12:RP87030. doi: 10.7554/eLife.87030.
Elife. 2024.
PMID: 39009040
Free PMC article.
Clinical Trial.